| 2D Structure | |
| CID | 135398501 |
| Target | ACP1 , AKT1 , AKT2 , AKT3 , CAMK1 , DRD3 , EEF2K , MYLK , NR5A1 , NR5A2 , NSD2 , PAK4 , PAX8 , RAD52 , TDP1 |
| IUPAC Name | 3-[1-[[4-(6-phenyl-8H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one |
| InChI | InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25,38H,14-17,20H2,(H,39,42) |
| InChI Key | IWCQHVUQEFDRIW-UHFFFAOYSA-N |
| Canonical SMILES | C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8 |
| Isomeric SMILES | C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8 |
| Molecular Formula | C34H29N7O |
| Molecular Weight | 551.6 |
| synonyms | ['Akt inhibitor VIII', '612847-09-3', 'Akti-1/2', 'YX4CPQ6V6X', 'Akt-I 1,2', '1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one', '1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)-piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', '3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one', '1-(1-(4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', 'Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2', '1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one', '1-(1-((4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', '1-{1-[(4-{6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one', '3-[1-[[4-(6-phenyl-8H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one', 'Akti-1-2 compound', 'Akt-I-1,2 compound', 'isozyme-selective, Akti-1/2', 'Akt Inhibitor VIII?', 'imidazoquinoxaline 16h', 'UNII-YX4CPQ6V6X', 'AKT-INHIBITOR-1-2', 'MLS003509084', 'MLS006010829', 'CHEMBL258844', 'GTPL5921', 'SCHEMBL1078972', 'CHEMBL4780754', 'BDBM15169', 'CHEBI:91346', 'DTXSID50436572', 'EX-A672', 'cid_10196499', 'HMS3229A11', 'HMS3265G03', 'HMS3265G04', 'HMS3265H03', 'HMS3265H04', 'BCP13210', 's7776', 'AKOS016008792', 'AKOS027470284', 'CCG-206733', 'FA17246', 'SDCCGSBI-0086657.P003', 'NCGC00165727-01', 'NCGC00165727-02', 'NCGC00165727-10', '1-(1-(4-(6-Phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', 'AS-56039', 'HY-10355', 'SMR002157258', 'SMR004701756', 'DB-362634', 'A3153', 'VU0450226-1', 'A-6730', 'Akt Inhibitor VIII trifluoroacetate salt hydrate', 'Q27074367', 'Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3', '1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]guinoxalin-7-yl)phenyl]methyl]4-piperidinyl]-2H-benzimidazol-2-one;', '1,3-Dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]4-piperidinyl]-2H-benzimidazol-2-one', '1,3-Dihydro-1-[1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenylmethyl]-4-piperidinyl]-2H-benzimidazol-2-one', '1-(1-(4-(7-Phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one', '1-(1-(phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one', '1-{1-[(4-{7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one', '1-{1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one', '2H-BENZIMIDAZOL-2-ONE, 1,3-DIHYDRO-1-(1-((4-(6-PHENYL-1H-IMIDAZO(4,5-G)QUINOXALIN-7-YL)PHENYL)METHYL)-4-PIPERIDINYL)-', '3-[1-[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]-4-piperidyl]-1H-benzimidazol-2-one', 'IQO'] |
From Pubchem